---
figid: PMC6274686__ijms-19-03419-g006
figlink: /pmc/articles/PMC6274686/figure/ijms-19-03419-f006/
number: F6
caption: Model of NOD1 signaling cascade. Nucleotide-binding oligomerization domain
  1 (NOD1) characterized by three motifs containing a C-terminal leucine-rich repeat
  (LRR) domain, a central nucleotide-binding domain (NBD), and a variable N-terminal
  caspase recruitment domains (CARD), which could be activated by γ-D-Glu-mDAP (IE-DAP).
  NOD1 recruits the adaptor RIP2 and facilitates recruitment of TAK1 and NEMO. Here
  the TAK1 recruits TAB1 and TAB2/3 inducing MAPK activation. In addition, NEMO instigates
  activation of NF-κB by reducing IκBα and phosphorylating P65, the subunit of NF-κB.
  Furthermore, activation of MAPK and NF-κB promotes the cell cycle and proliferation.
  In our study, Evodiamine could potentially suppress the NOD1 signal pathway to inhibit
  the cell cycle and proliferation. The arrows represents the activation and the T
  bar represents the suppression.
pmcid: PMC6274686
papertitle: Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing
  NOD1 Signal Pathway.
reftext: Xing-Xian Guo, et al. Int J Mol Sci. 2018 Nov;19(11):3419.
pmc_ranked_result_index: '13747'
pathway_score: 0.9602057
filename: ijms-19-03419-g006.jpg
figtitle: NOD1 signaling cascade
year: '2018'
organisms:
- Homo sapiens
ndex: 087cb36d-dedd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6274686__ijms-19-03419-g006.html
  '@type': Dataset
  description: Model of NOD1 signaling cascade. Nucleotide-binding oligomerization
    domain 1 (NOD1) characterized by three motifs containing a C-terminal leucine-rich
    repeat (LRR) domain, a central nucleotide-binding domain (NBD), and a variable
    N-terminal caspase recruitment domains (CARD), which could be activated by γ-D-Glu-mDAP
    (IE-DAP). NOD1 recruits the adaptor RIP2 and facilitates recruitment of TAK1 and
    NEMO. Here the TAK1 recruits TAB1 and TAB2/3 inducing MAPK activation. In addition,
    NEMO instigates activation of NF-κB by reducing IκBα and phosphorylating P65,
    the subunit of NF-κB. Furthermore, activation of MAPK and NF-κB promotes the cell
    cycle and proliferation. In our study, Evodiamine could potentially suppress the
    NOD1 signal pathway to inhibit the cell cycle and proliferation. The arrows represents
    the activation and the T bar represents the suppression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK8
  - MAPK11
  - IKBKB
  - IKBKG
  - CHUK
  - MAPK1
  - MAPK3
  - NFKBIA
  - MAPK13
  - MAPK12
  - MAPK9
  - MAPK10
  - MAPK14
  - TAB3
  - NFKB1
  - TAB2
  - Evodiamine
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: IKBA
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: TAB2/3
  symbol: TAB3
  source: hgnc_symbol
  hgnc_symbol: TAB3
  entrez: '257397'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: NF-kB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: TAB2/3
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
chemicals:
- word: Evodiamine
  source: MESH
  identifier: C049639
diseases: []
figid_alias: PMC6274686__F6
redirect_from: /figures/PMC6274686__F6
figtype: Figure
---
